Eight weeks of intravenous thymopentin in active rheumatoid arthritis
Study involving people · 1991
- What was studied
- 20 people with active rheumatoid arthritis at Hanyang University, Seoul. There was no comparison group.
- Main finding
- Study-defined response at six to eight weeks · 11/20 responded. Two improved in functional class and nine showed mild symptom improvement. Seven were unchanged and two worsened. No remission was reported.
Reported findings and study design
Reported findings
50 mg thymopentin mixed with 10 mL saline, infused IV over 10 minutes three times weekly for eight weeks. Existing NSAIDs continued at unchanged doses. Corticosteroids and disease-modifying antirheumatic drugs were withheld during treatment.
Population or model 20 people with active rheumatoid arthritis at Hanyang University, Seoul. There was no comparison group.
Dose, route and schedule
50 mg thymopentin mixed with 10 mL saline, infused IV over 10 minutes three times weekly for eight weeks. Existing NSAIDs continued at unchanged doses. Corticosteroids and disease-modifying antirheumatic drugs were withheld during treatment.
Protocol source ↗ · Original Korean full text, including Tables 1, 3 and 5.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Study-defined response at six to eight weeks | 11/20 responded. Two improved in functional class and nine showed mild symptom improvement. Seven were unchanged and two worsened. No remission was reported. | |
| Follow-up and safety | Only three still showed improvement six weeks after treatment ended. Three participants had transient adverse effects, and none stopped treatment because of them. |
The response rule was specific to the study, and changes from baseline came from an uncontrolled single-center series.
Source for these results ↗ · Reviewed 2026-11-14
Study limitations and source details
Study limitations
- The response rule was specific to the study, and changes from baseline came from an uncontrolled single-center series.
Source details
Original Korean full text, including Tables 1, 3 and 5.
Sources checked
Added to the library
Citation
D. H. Yoo, S. C. Bae, C. H. Park, S. Y. Kim. Eight weeks of intravenous thymopentin in active rheumatoid arthritis Korean Journal of Internal Medicine (Korean-language edition) 41(4), 518–524